default logo


Flow Cytometry

This powerful technique enables rapid identification and sorting of cells, streamlining the manufacture of many biologic pharmaceuticals. In the manufacture of many types of biologics, flow cytometry is a crucial tool for identifying, analyzing and sorting cells. This technique can pr
Continue Reading →

The Vero Vaccine Production Pipeline

The Vero platform’s upstream and downstream processing stages are designed for maximum efficiency and safety, as well as purity of the final product. Despite many recent advances in vaccine development technology, the actual process of bringing new vaccines to the clinical trial stage
Continue Reading →

Advanced Development and Manufacturing of Antibody Technologies (ADAMANT)

This cutting-edge platform streamlines antibody development and optimizes production. Over the past several years, the US Food and Drug Administration (FDA) has rolled out its Medical Countermeasures Initiative (MCMi), aimed at establishing clearer regulatory pathways for medical prod
Continue Reading →

Vero Cell Platform Technology

The cell development platform has proven effective in the creation of a number of viral vaccines. Recent years have witnessed a significant amount of innovation in technologies for the development of novel vaccines. These technologies include new vector systems for delivering attenuat
Continue Reading →

Clinical Stage Products

Emerging technologies offer exciting opportunities for the development of novel therapies. Although commercial sales are certainly a desirable target for pharmaceutical development, they’re far from the only reason to invest in new products. In a number of fields, pharma developers ar
Continue Reading →

New Investments and Approvals Spur the Development of Biologics

Although still expensive to develop and produce, large molecules are rapidly taking over. For most of the previous century, much of pharmaceutical research focused on the development of small-molecule “blockbuster” drugs, which treated a wide variety of diseases for a great number of
Continue Reading →

Development of Biologics – Monoclonal Antibodies

Approval success rates vary widely, but are on the increase overall. The human monoclonal antibody (mAb) sector has witnessed tremendous growth since its inception in the early 1980s. Despite a rocky start, new technologies in molecule generation spurred rapid development throughout t
Continue Reading →

Sterile Injectables for Clinical Trials

Growth continues, but logistical and regulatory hurdles limit worldwide supplies The global market for sterile injectables continues to expand at an impressive rate. In 2015, this market was valued at $299.7 billion; and its compound annual growth rate (CAGR) is projected at 6.9 perce
Continue Reading →